ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s stock price was down 2.2% during mid-day trading on Monday . The company traded as low as $2.69 and last traded at $2.72. Approximately 601,992 shares traded hands during mid-day trading, an increase of 2,862% from the average daily volume of 20,327 shares. The stock had previously closed at $2.78.
ImmunoPrecise Antibodies Trading Down 2.2%
The company’s 50-day simple moving average is $1.86 and its 200 day simple moving average is $1.89.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd (OTCMKTS:IPATF) is a Canada-based contract research organization specializing in the discovery and development of therapeutic antibodies. The company provides a full suite of preclinical research services, from target validation and lead identification through to humanization and optimization. Its capabilities encompass hybridoma, phage display, single B cell sorting and next-generation sequencing platforms to accelerate antibody candidate selection and characterization.
ImmunoPrecise serves biopharmaceutical and biotechnology partners worldwide, offering customized solutions for projects in immuno-oncology, infectious diseases, autoimmunity and other therapeutic areas.
See Also
- Five stocks we like better than ImmunoPrecise Antibodies
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- Gold Breakout ALERT
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
